AKT1 and prostate cancer: Expression of mutant SPOP activates PI3K/AKT pathway and upregulates AR signaling, maintaining AR transcriptional activity against PI3K/AKT‐mediated negative feedback, effectively activating the two most common driver pathways critical in prostate cancer.